Skip to main content
. 2020 Jan 27;68(7):2082–2090. doi: 10.1021/acs.jafc.9b07361

Figure 2.

Figure 2

In situ evaluation of the ACE activity. Soy1 and LPYP reduce in situ the ACE activity with a dose-response trend (A) in nondifferentiated human Caco-2 cells (IC50 values equal to 14.7 ± 0.28 and 5.0 ± 0.28 μM, respectively) and (B) in renal HK-2 cells (IC50 values equal to 6.0 ± 0.35 and 6.8 ± 0.20 μM, respectively). Data represent the mean ± s.d. of three independent experiments performed in triplicate.